Sector: Health Care
Director information for DANAHER CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alan G. Spoon | Former Managing General Partner; Director | 74 | ["Partner Emeritus of Polaris Partners", "Managing General Partner from 2000 to 2010", "Chief Operating Officer and Chief Financial Officer of a large education and media company", "Board member of Cable One, Inc., Match Group, and Fortive Corporation", "Experience in business strategy, leadership and executive compensation", "Insight into technology and life science trends, acquisition strategy and financing"] | ["A", "Compensation", "Audit"] | 2026 |
| A. Shane Sanders | Former Senior Vice President of Business Transformation; Director; Chair | 63 | ["Senior Vice President of Business Transformation at Verizon Communications Inc.", "Senior Vice President of Corporate Finance at Verizon Communications Inc.", "Leadership in Verizon\u2019s accounting and finance organization", "Experience in cybersecurity and IT security risk management", "Various finance roles at Hallmark Cards, Inc. and Safelite Group, Inc.", "Career began at Grant Thornton in 1984"] | ["l", "Audit", "Nominating & Governance", "Audit Committee", "Nominating & Governance Committee"] | 2026 |
| Charles W. Lamanna | Executive Vice President, Agents and Business Apps | 38 | ["Leadership experience in AI", "Driving product innovation in AI-powered business applications", "Experience in low-code platforms and autonomous agents", "Oversight of design, product development, and engineering", "Founder and CEO of MetricsHub", "Key role in developing Microsoft Azure\u2019s infrastructure"] | ["A", "Science & Technology", "Nominating & Governance", "Science & Technology Committee"] | 2026 |
| Elias A. Zerhouni, MD | President and Vice Chairman; Director | 74 | ["President and Vice Chairman of the Board of OPKO Health, Inc.", "Chairman and co-founder of ModeX Therapeutics Inc.", "President, Global Research & Development, for Sanofi S.A.", "Director of the National Institutes of Health", "Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences", "Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine", "Widely viewed as a leading authority in radiology research"] | ["A", "l", "Science & Technology (Chair)", "Nominating & Governance", "Audit", "Compensation", "Nominating & Governance Committee", "Science & Technology Committee"] | 2026 |
| Feroz Dewan | Chief Executive Officer; Director | 49 | ["Chief Executive Officer of Arena Holdings Management LLC since 2016", "Experience in the technology industry", "Experience with valuations, investments and acquisitions", "Financial reporting", "Risk management", "Corporate governance", "Capital allocation", "Operational oversight"] | ["A", "C", "Finance", "Nominating & Governance", "Science & Technology", "Audit", "Compensation", "Nominating & Governance Committee", "Science & Technology Committee"] | 2026 |
| John T. Schwieters | [] | ["Audit", "Audit Committee", "Nominating & Governance Committee"] | 2026 | ||
| Linda Filler | Former President of Retail Products, Chief Marketing Officer, and Chief Merchandising Officer; Director; Chair | 66 | ["Retired President of Retail Products at Walgreen Co.", "Chief Marketing Officer at Walgreen Co.", "Chief Merchandising Officer at Walgreen Co.", "President, North America of Claire\u2019s Stores, Inc.", "Executive Vice President roles at Walmart Inc.", "Roles at Kraft Foods, Inc.", "Chief Executive Officer roles at Hanesbrands Inc.", "General management responsibilities", "Marketing, branding and merchandising expertise"] | ["l", "o", "Nominating & Governance", "Science & Technology", "Compensation", "Nominating & Governance Committee", "Science & Technology Committee"] | 2026 |
| Mitchell P. Rales | Chairman of the Executive Committee | 69 | ["Co-founder of Danaher", "Chairman of the Executive Committee since 1984", "President of the Company from 1984 to 1990", "Strategic vision and leadership", "Substantial ownership stake in Danaher"] | ["l", "Executive", "Finance", "Nominating & Governance"] | 2026 |
| M. Rales | 69 | ["Global/International", "Product Innovation", "M&A", "Public Company CEO and/or President", "Finance"] | [] | 2026 | |
| Rainer M. Blair | President and Chief Executive Officer | 61 | ["President and Chief Executive Officer since September 2020", "Served in a series of progressively more responsible general management positions since joining Danaher in 2010", "In-depth knowledge of Danaher\u2019s businesses and of the Danaher Business System", "Leadership experience from service in the U.S. Army", "Deep multi-cultural experience having lived and worked on three continents"] | ["A", "C", "N", "Executive", "Finance", "Science & Technology", "Audit", "Compensation", "Nominating & Governance", "Science & Technology Committee"] | 2026 |
| Raymond C. Stevens, PhD | Chief Executive Officer | 62 | [] | ["A"] | 2026 |
| Raymond C. Stevens, PH.D. | Director | 62 | ["Chief Executive Officer of Structure Therapeutics", "Provost Professor of Biological Sciences and Chemistry at the University of Southern California", "Founder and Director of The Bridge Institute", "Professor of Molecular Biology and Chemistry with The Scripps Research Institute", "Experience in launching biotechnology companies focused on drug discovery", "Expertise in human cellular behavior research", "Involvement in the creation of therapeutic molecules", "Extensive experience living and working in China"] | ["Audit", "Science & Technology", "Audit Committee", "Science & Technology Committee"] | 2026 |
| S. Rales | 74 | ["Global/International", "M&A", "Public Company CEO and/or President"] | [] | 2026 | |
| Steven M. Rales | Chairman of the Board | 74 | ["Co-founder of Danaher", "Former CEO of the Company from 1984 to 1990", "Strategic vision and leadership", "Understanding of shareholders' rights and interests"] | ["A", "C", "N", "Executive", "Finance", "Science & Technology", "Audit", "Compensation", "Science & Technology Committee"] | 2026 |
| Teri L. List | Former Executive Vice President and Chief Financial Officer; Director | 63 | ["Executive Vice President and Chief Financial Officer of Gap Inc.", "Executive Vice President and Chief Financial Officer of Dick\u2019s Sporting Goods, Inc.", "Advisor at Kraft Foods Group, Inc.", "Senior Vice President of Finance at Kraft Foods Group, Inc.", "Senior Vice President and Treasurer at Procter & Gamble Company", "Experience at Deloitte & Touche", "Board member of Oscar Health, Inc. and DoubleVerify Holdings, Inc.", "Decades of financial and leadership experience", "Expertise on risk management, strategic planning, and financial oversight", "Experience in corporate finance and accounting"] | ["A", "l", "Audit", "Compensation", "Audit Committee"] | 2026 |
